Clinical Trial Detail

NCT ID NCT03472560
Title A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Pfizer

lung non-small cell carcinoma

transitional cell carcinoma


Avelumab + Axitinib

Age Groups: adult senior

Additional content available in CKB BOOST